Crossmark

Stimuli-responsive combination therapy of cisplatin and Nrf2 siRNA for improving antitumor treatment of osteosarcoma

Published Online: 2020-03-18

Published Print: 2020-03

Authors

Gu, Ting-Ting

Li, Chengjun

Xu, Yurui

Zhang, Lei

Shan, Xue

Huang, Xinyu

Guo, Leilei

Chen, Kerong

Wang, Xiaojian

Ge, Haixiong

Ning, Xinghai
License Information

Text and Data Mining valid from 2020-03-01

Version of Record valid from 2020-03-01
More Information

Article History

Received: 27 November 2019

Revised: 13 January 2020

Accepted: 14 January 2020

First Online: 18 March 2020

Document is current